• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Characterization of increased cryptogenic ischemic stroke risk from smoking

byPaary BalakumarandAlex Chan
May 19, 2025
in Chronic Disease, Neurology
Reading Time: 2 mins read
Strict tobacco licensing laws linked to reduced adolescent smoking initiation
Share on FacebookShare on Twitter

1. Smoking had a strong association with young cryptogenic ischemic stroke that was more pronounced in men and peaked in the 45-49 age group

2. Smoking greater than 20 pack years was necessary to see an association after adjusting for confounding variables

Evidence Rating Level: 2 (Good) 

This multicenter case-control study examined the association between smoking and cryptogenic ischemic stroke (CIS) in young adults aged 18–49, using data from the SECRETO study. As CIS accounts for up to 28% of strokes in this age group and smoking is a modifiable vascular risk factor, the study aimed to clarify smoking’s role in young CIS incidence. A total of 546 young patients with CIS (47.3% female) and 546 age- and sex-matched controls were analyzed. Smoking status and intensity (pack years) were assessed through standardized questionnaires, and conditional logistic regression adjusted for education level and vascular risk factors (hypertension, diabetes, obesity, alcohol use, etc.) was used. There was a strong association between smoking and young CIS (adjusted OR 2.39, 95% CI 1.65–3.47). The risk was more pronounced in men (OR 3.34) than women (OR 1.65) and peaked in the 45–49 age group (OR 3.77). Heavy smoking (>20 pack years) showed the strongest link to CIS (OR 4.30), especially in men (OR 6.97). Notably, no significant association emerged in women or those smoking fewer than 20 pack years after adjusting for confounders. These findings highlight smoking as an independent risk factor for young CIS, with risk intensifying with smoking intensity and age, particularly among men. The study underscores the need for targeted smoking cessation strategies and more research into sex-specific mechanisms underlying CIS.

Click to read the study in Neurology

Image: PD

RELATED REPORTS

A healthy lifestyle may reduce risk of infection in patients with type 2 diabetes

One in four National Football League (NFL) players who died between 2016-2021 had evidence of chronic traumatic encephalopathy

Brain-predicted age difference may reliably predict dementia progression

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

Tags: chronic diseasecryptogenic strokeneurologysmokingstroke
Previous Post

Prevalence of common chronic conditions in Medicare Advantage and traditional Medicare beneficiaries

Next Post

#VisualAbstract: Addition of Aerobic Physical Activity to Resistance Exercise Does Not Improve Pain or Function in Hip Osteoarthritis

RelatedReports

Reduced gestational weight gain with lifestyle intervention
Chronic Disease

A healthy lifestyle may reduce risk of infection in patients with type 2 diabetes

September 2, 2026
Chronic Disease

One in four National Football League (NFL) players who died between 2016-2021 had evidence of chronic traumatic encephalopathy

August 27, 2026
Chronic Disease

Brain-predicted age difference may reliably predict dementia progression

August 19, 2026
No difference in mortality for intensive versus standard reduction in blood pressure in intracerebral hemorrhage: The ATACH-2 trial
Emergency

Diffusion-weighted imaging may aid in prognostication for intracerebral hemorrhage

August 18, 2026
Next Post
#VisualAbstract: Addition of Aerobic Physical Activity to Resistance Exercise Does Not Improve Pain or Function in Hip Osteoarthritis

#VisualAbstract: Addition of Aerobic Physical Activity to Resistance Exercise Does Not Improve Pain or Function in Hip Osteoarthritis

Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults

Maternal obesity associated with increased risk of perinatal ischemic stroke

Quick Take: Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial

Home-based dynamic intermittent pneumatic compression therapy improves chronic stroke outcomes

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Male sex is associated with higher mortality among patients with hepatocellular carcinoma
  • Artificial intelligence (AI)-supported symptom self-assessment led to more appropriate patient care-seeking decisions
  • Rimegepant (Nurtec ODT) may be an effective alternative to triptans for symptom relief in migraines
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.